Five pronged strategy

Desai, Suresh Thakur
December 1997
Chemical Business;Dec97, Vol. 11 Issue 5, p23
Trade Publication
Reports on the five-pronged strategy for bulk actives by Hyderabad, India-based Dr. Reddy's Laboratories to sustain its profitability.


Related Articles

  • Dr Reddy's Laboratories--good show.  // Chemical Business;Jul98, Vol. 12 Issue 7, p116 

    Reports on the financial performance of the Dr. Reddy's Laboratories company in fiscal year 1997-98. Turnover growth of the formulations business; Formulations sales in India; Sales of the bulk drugs business.

  • Dr Reddy's to expand bulk drug activities.  // Chemical Business;Aug95, Vol. 9 Issue 1, p30 

    Reports that Indian company Dr. Reddy's Lab is contemplating expanding its activities in the fields of bulk drugs as also formulations. Set up of unit by company; Costs; Other expansion by company.

  • Dr. Reddy's seeks global patents for 4 products.  // Chemical Business;Jun95, Vol. 8 Issue 11, p64 

    Reports on Dr. Reddy's Laboratories' efforts to obtain world-wide patents for four of its products. Search for joint venture partners in Russia and China; Increased demand for cheap generic substitutes in the United States.

  • Dr. Reddy's Laboratories Inc.  // Pharmaceutical Technology;Dec2010 Supplement, p92 

    The article presents the corporate profile of Dr. Reddy's Laboratories Inc., located in Bridgewater, New Jersey, where it was established in 1984 and has 14,000 active employees.

  • Dr Reddy's launches Sildenafil tablets.  // BioSpectrum;Dec2012, Vol. 10 Issue 12, p14 

    The article reports that Sildenafil tablets, a bioequivalent generic version of REVATIO (Sildenafil) tablets, has been launched by Dr. Reddy's Laboratories.

  • DRL donates Rs 2 crs to Hudhud cyclone relief fund.  // Express Pharma;03/16/2014, p2 

    The article reports on the donation of Dr. Reddy's Laboratories Ltd. of about Rs two crores to Hudhud cyclone relief fund in a bid to help restore the lives of the people affected by the cyclone in Visakhapatnam.

  • DRL launches esomeprazole magnesium delayed-release capsules.  // Express Pharma;9/28/2015, p1 

    The article reports on the launch of esomeprazole magnesium delayed-relese capsules by Dr. Reddy's Laboratories Ltd. (DRL) in the U.S. market on September 25, 2015.

  • Dr Reddy's lotion for vitiligo.  // BioSpectrum;Jul2014, Vol. 12 Issue 7, p14 

    The article reports on the launch of a Melgain lotion by pharmaceutical giant Dr. Reddy's Laboratories Ltd. in-licensed with city-based Issar Pharmaceuticals for the domestic market.

  • Dr. Reddy's Laboratories submits press release.  // Ace Analyser: Company News;6/14/2019, pN.PAG 

    The article informs that Dr. Reddy's Laboratories has announced entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories LLC.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics